Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
With the approval of Cyramza, there are now five targeted therapies for hepatocellular carcinoma.
This finding was especially pronounced among those with cirrhosis, a history of depression, liver disease progression or liver cancer.
Needle exchanges are being endorsed and legalized in a number of red states.
It’s Hepatitis Awareness Month. Find out if money poses a risk for transmitting viral hepatitis.
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
The CDC has released a new hepatitis A surveillance report.
The herbicide has been making headlines over allegations it could be linked to cancer—but scientists say there are other risks too.
Just over half of people who use drugs in eight cities are hepatitis C virus antibody positive.
Scientists say they have developed a new 3-D printing technique that can produce viable organ tissues.
Such a vaccine would make inoculation easier in developing nations, where the need is great.
Do you know what the healthiest diet is? A look at what the experts say.
This is compared with providing people who inject drugs with hep C drugs to take independently.
Plaintiffs in Georgia, Michigan, Kansas and Missouri say new rules will leave less populous areas with fewer organs than urban regions.
Bulevirtide plus pegylated interferon shows promise for hard-to-treat coinfection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.